Abstract: Cardiovascular diseases during pregnancy is one of the most severe causes of maternal death.Since the European Society of Cardiology（ESC） issued the Guidelines for the Management of Cardiovascular Diseases during Pregnancy in 2011，new evidences have accumulated，particularly in diagnostic techniques，risk assessment，and the use of cardiovascular drugs.Therefore，the ESC revised the guideline and published a new one in August 2018.It provides detailed introduction of pre-pregnancy counseling，risk assessment，management，diagnosis and treatment of cardiovascular diseases during pregnancy，and drug use during pregnancy，especially risk factors.We are lack of corresponding clinical guidelines in China，but the number of pregnant patients with cardiovascular diseases is rising.In this paper，the main updated points of the guideline are interpreted to provide references for clinical diagnosis and treatment of cardiovascular diseases during pregnancy in China.

Key words: Cardiovascular diseases, Pregnancy, Disease management, Guideline

摘要： 妊娠期心血管疾病严重危害孕产妇健康，是导致孕产妇死亡的重要原因之一。自2011年欧洲心脏病学会（ESC）发布《妊娠期心血管疾病的管理指南》以来，又出现了很多新的证据，尤其是诊断技术、风险评估以及心血管药物使用方面。因此ESC修订了该指南，并于2018年8月发表，即《2018 ESC妊娠期心血管疾病管理指南》，对妊娠期心血管疾病的妊娠前咨询、风险评估、妊娠期管理及诊治、妊娠期药物使用等方面进行了详细阐述，更加强调风险评估。我国尚缺乏相应的临床指南，但合并有心血管疾病的妊娠患者越来越多，本文就该指南的主要更新要点进行解读，旨在为我国妊娠期心血管疾病临床诊疗提供参考。

关键词: 心血管疾病, 妊娠, 疾病管理, 指南